Hormone replacement therapy, cardiovascular risk factors and diabetes

Journal of the British Menopause Society

Volumn 6, Issue 3, 2000, Pages 94-98

  Smith, M R ^a   Feher, M D ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Coronary heart disease; Diabetes; Dyslipidaemia; Glycaemic control hormone replacement therapy

Indexed keywords

CONJUGATED ESTROGEN; DYDROGESTERONE; ESTRADIOL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROGESTERONE;

ATHEROGENESIS; BLOOD PRESSURE; BONE DENSITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; ENDOTHELIUM; ESTROGEN DEFICIENCY; FEMALE; FIBRINOLYSIS; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HORMONAL THERAPY; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

EID: 0033812814     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218000129569430     Document Type: Review

References (35)

1. Why is diabetes mellitus a stronger risk factor for fatal ischaemic heart disease in women than men?
2. Coronary heart disease in women with diabetes
3. Lipid modification and coronary heart disease in type 2 diabetes: Different from the general population?
4. Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women
5. Influence of age and menopause on serum lipids and lipoproteins in healthy women
6. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women
7. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow-up study of the Lipid Research Clinics Prevalence Study
8. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations
9. Magnitude and determinants of coronary artery disease in juvenile onset, insulin dependent diabetes mellitus
10. Arterial thrombosis in atherosclerosis in diabetes
11. The fibrinolytic system in diabetes mellitus
12. Endothelial dysfunction: Cause of the insulin resistance syndrome
13. Insulin as a vascular hormone: Implications for the pathophysiology of cardiovascular disease
14. Impaired nitric oxide mediated vasodilatation in patients with non insulin dependent diabetes mellitus
15. Impaired endothelium dependent vasodilatation in women with previous gestational diabetes
16. Increased serum concentration of von Willebrand factor in non insulin dependent diabetic patients with and without diabetic nephropathy
17. Is hormone replacement therapy prescribed for postmenopausal diabetic women?
18. Do women with diabetes receive hormone replacement therapy?
19. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women
20. Effects of oestrogen or oestrogen/progestin regimens on heart disease risk factors in postmenopausal women
21. Hormone replacement therapy with dydrogesterone and 17β-oestradiol: Effects on serum lipoproteins and glucose tolerance
22. Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
23. The effect of postmenopausal oestrogen therapy on the risk of non insulin dependent diabetes mellitus
24. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
25. Oestrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with non insulin dependent diabetes mellitus
26. Short term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
27. Short term blood pressure and metabolic effects of tibolone in postmenopausal women with non insulin dependent diabetes
28. Can postmenopausal hormone replacement improve plasma lipids in women with diabetes?
29. Estrogen improves endothelium-dependent flow-mediated vasodilation in postmenopausal women
30. The effect of oestrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women
31. The effects of oestrogen replacement therapy on haemostasis variables in postmenopausal women with non-insulin dependent diabetes mellitus
32. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
33. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
34. Bone mineral density in patients with type 1 and type 2 diabetes
35. The effect of transdermal oestrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM